DrugPatentWatch Database Preview
Desoximetasone - Generic Drug Details
What are the generic drug sources for desoximetasone and what is the scope of desoximetasone freedom to operate?
Desoximetasone
is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Akorn, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising Pharms, Zydus Pharms Usa Inc, Taro Pharm Inds Ltd, Altana, G And W Labs Inc, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Taro Pharms, and is included in thirty-eight NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Desoximetasone has four patent family members in four countries.
There are seven drug master file entries for desoximetasone. Nineteen suppliers are listed for this compound.
Summary for desoximetasone
International Patents: | 4 |
US Patents: | 3 |
Tradenames: | 3 |
Applicants: | 15 |
NDAs: | 38 |
Drug Master File Entries: | 7 |
Suppliers / Packagers: | 19 |
Bulk Api Vendors: | 37 |
Clinical Trials: | 9 |
Patent Applications: | 6,116 |
Drug Prices: | Drug price information for desoximetasone |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for desoximetasone |
DailyMed Link: | desoximetasone at DailyMed |
Pharmacology for desoximetasone
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for desoximetasone
Synonyms for desoximetasone
(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione |
(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one |
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one |
17-Deoxymethansone |
17-Desoximethasone |
382-67-2 |
382D672 |
4E07GXB7AU |
9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione |
9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione |
9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dione |
9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone |
A 41-304 |
A 41304 |
A-41-304 |
AB2000738 |
AC1NSJXQ |
AKOS030254657 |
AS-15787 |
BDBM50103622 |
BRN 2228097 |
C-55186 |
CAS-382-67-2 |
CCG-101120 |
CHEBI:691037 |
CHEMBL1766 |
CS-3002 |
CTK8F9086 |
D03697 |
D0CZ1Q |
DB00547 |
Deoxymethasone |
Desossimetasone |
Desossimetasone [DCIT] |
Desoximetason |
Desoximetasona |
Desoximetasona [INN-Spanish] |
Desoximetasone (USP/INN) |
Desoximetasone [USAN:USP:INN:BAN] |
Desoximetasonum |
Desoximetasonum [INN-Latin] |
desoximethasone |
Desoxymetasone |
Desoxymethasone |
DSSTox_CID_25647 |
DSSTox_GSID_45647 |
DSSTox_RID_81025 |
DTXSID3045647 |
EINECS 206-845-3 |
Esperson |
Flubason |
GTPL7067 |
HMS2052C15 |
HMS2236H07 |
HOE 304 |
HOE-304 |
HY-17570 |
Ibaril |
MLS000028654 |
MLS001076073 |
MLS001424230 |
MolPort-003-941-111 |
NC00370 |
NCGC00023648-03 |
NCGC00023648-04 |
Opera_ID_52 |
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)- |
Q-200938 |
Q790 |
R 2113 |
R-2113 |
SC-46986 |
SCHEMBL4214 |
SMR000058856 |
Stiedex |
Topicort |
Topicort (TN) |
Topicort Emollient (TN) |
Topicort LP |
Topisolon |
Tox21_110889 |
Tox21_110889_1 |
UNII-4E07GXB7AU |
VWVSBHGCDBMOOT-IIEHVVJPSA-N |
ZINC4212854 |
US Patents and Regulatory Information for desoximetasone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro Pharm Inds Ltd | TOPICORT | desoximetasone | OINTMENT;TOPICAL | 074286-001 | Jun 7, 1996 | AB | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Rising Pharms | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 204272-001 | Nov 30, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Perrigo New York | DESOXIMETASONE | desoximetasone | CREAM;TOPICAL | 076510-001 | Jul 1, 2003 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Glenmark Generics | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 202838-001 | Sep 20, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Perrigo Israel | DESOXIMETASONE | desoximetasone | SPRAY;TOPICAL | 206441-001 | Jan 20, 2017 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for desoximetasone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | ➤ Sign Up | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for desoximetasone
Country | Document Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2006130510 | ➤ Sign Up |
Israel | 187666 | ➤ Sign Up |
European Patent Office | 1888026 | ➤ Sign Up |
Canada | 2609579 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:









Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.